Over the last five years, the use of digital measurements captured by digital sensors and devices in clinical trials has steadily increased. Among other benefits, device-supported trials can use novel methods to obtain patient data, which reduces the need for in-person data collection and improves the participant experience. However, obstacles remain in the life sciences industry to adopt these measurements. In this webinar, Craig Lipset, co-chair of DTRA, and Jeff Gombala, associate principal at ZS, discuss how healthtech companies and life sciences organizations can work together to accelerate the adoption of novel digital endpoints.
Watch this on-demand webinar to learn:
- The value derived from novel digital endpoints
- How to overcome adoption hurdles due to technology apprehension
- How to generate evidence in collaboration with life sciences organizations